Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionVisionPoint Advisory Group, LLC
Latest Disclosed Ownership3,360 shares
Latest Disclosed Value $ 1,182,218
VisionPoint Advisory Group, LLC reports 12.09% decrease in ownership of AMGN / Amgen Inc.

On May 7, 2026 - VisionPoint Advisory Group, LLC filed a 13F-HR form disclosing ownership of 3,360 shares of Amgen Inc. (MX:AMGN) valued at $1,182,218 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 12, 2026 disclosing 3,822 shares of Amgen Inc.. This represents a change in shares of -12.09% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F AMGEN COM 031162100 3,360 -462 -12.09 1,182 -5.44 0.2228
2026-01-12 2025-12-31 13F AMGEN COM 031162100 3,822 74 1.97 1,251 18.26 0.2437
2025-10-08 2025-09-30 13F AMGEN COM 031162100 3,748 247 7.06 1,058 8.19 0.2110
2025-07-09 2025-06-30 13F AMGEN COM 031162100 3,501 -1,873 -34.85 978 -41.64 0.2126
2025-04-23 2025-03-31 13F AMGEN COM 031162100 5,374 -184 -3.31 1,674 16.17 0.5738
2025-02-03 2024-12-31 13F AMGEN COM 031162100 5,558 542 10.81 1,441 -10.83 0.4927
2024-10-15 2024-09-30 13F AMGEN COM 031162100 5,016 881 21.31 1,616 25.17 0.5456
2024-08-01 2024-06-30 13F AMGEN COM 031162100 4,135 610 17.30 1,292 28.84 0.4592
2024-05-10 2024-03-31 13F AMGEN COM 031162100 3,525 1,817 106.38 1,002 104.07 0.3613
2024-02-07 2023-12-31 13F AMGEN COM 031162100 1,708 1,049 159.18 492 177.40 0.1815
2023-12-06 2023-09-30 13F AMGEN COM 031162100 659 534 427.20 177 555.56 0.0759
2023-08-21 2023-06-30 13F AMGEN COM 031162100 125 125 28 0.0113
2021-11-08 2021-09-30 13F AMGEN COM 031162100 0 -6,085 -100.00 0 -100.00
2021-08-10 2021-06-30 13F AMGEN COM 031162100 6,085 -2,024 -24.96 1,483 -26.51 0.6608
2021-05-14 2021-03-31 13F AMGEN COM 031162100 8,109 -796 -8.94 2,018 -1.42 0.9668
2021-02-08 2020-12-31 13F AMGEN COM 031162100 8,905 8,905 2,047 1.0318
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.